AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Neuronal Monoclonal Antibodies (NeuroMabs)

Technology Application

These NeuroMabs can be used to recognize endogenous target proteins in tissue and recombinant proteins with established links to disease states.

Detailed Technology Description

In addition to the high quality monoclonal antibodies available for purchase at the UC Davis/NIH Neuromab Facility, many NeuroMab hybridomas are available for non-exclusive licensing. Please see the Neuromab Catalog (see www.neuromab.ucdavis.edu) for NeuroMabs and datasheets. Additional NeuroMabs are added as they become available. (Note: not all NeuroMabs present in the NeuroMab Catalog may be available for licensing from UC.)

Others

Related Materials

The UC Davis NINDS/NIMH NeuroMab Hybridoma Facility
UC Davis/NIH NeuroMab Facility

Related Technologies

Anti-MMP9, Anti-Menke's Disease, and Anti-Wilson's Disease mAbs

Additional Technologies by these Inventors

Tech ID/UC Case

11194/2006-468-0

Related Cases

2006-468-0

Country/Region

USA

For more information, please click Here